Abundance of Sinopharm jabs available: CRA
The Chulabhorn Royal Academy (CRA) has given assurances there will be enough Sinopharm vaccine to go around if no one exceeds their allocation or jumps the queue.
CRA secretary-general Dr Nithi Mahanonda said on his Facebook page that millions of doses of Sinopharm vaccine have been ordered for local distribution.
However, they cannot be delivered to Thailand all at once as the production process, quality control and inspection take some time to complete. Everyone needs to be patient, he said.
"Please wait your turn and do not try to call me or Line-chat with me and ask for a VIP pass to cut the [allocation] queue. I cannot do that for you," Dr Nithi said. He is believed to be referring to companies or organisations at the bottom of the list hoping for a boost.
Many in vulnerable groups including monks, the elderly and those living in crowded communities have not received their first jabs -- they need to be taken care of first, he said, adding more time is needed to inspect the vaccine after its delivery to Thailand.
Dr Nithi said companies and organisations which could not order the Sinopharm vaccine earlier, need to be patient until the current backlog of orders is cleared. Then, they can place orders.
"There are no shortcuts or special treatment whatsoever," he said.
The supply of vaccine will be delivered gradually, and the inspection of its quality usually takes a few days.
He said the CRA should not be blamed for any delay in vaccinations at hospitals as the academy had sent supplies to them ahead of time. "If there has been any delay, it is an internal issue related to the hospitals," Dr Nithi added.
In the current first phase of distribution of Sinopharm by the CRA, the vaccine is free. "If anyone has had to pay money for it, you have been duped," he said.
Meanwhile, the CRA said yesterday a total 67,992 people were vaccinated with the Sinopharm formula between June 25-30. Of those, 16,823 were given jabs at the CRA which found, during post-appointment monitoring, that 48 had experienced undesirable side-effects following the vaccination.